SUBSTIPHARM
Celine Ly has worked as a Chief Financial Officer at SUBSTIPHARM since November 2010. Before that, Celine was a Controleur financier at DDB from 2007 to 2010. Prior to that, Celine worked as an Auditeur at KPMG from 2005 to 2007 and as a Controle de gestion at Valeo in 2005. Celine graduated from Audencia.
SUBSTIPHARM
Substipharm is a privately held pharmaceutical Group. We develop, supply and commercialize pharmaceuticals in more than 60 countries worldwide. Our portfolio of products that we currently license out or distribute directly or through partners comprises more than 60 different molecules. Our development pipeline includes as well more than 40 ongoing projects. We have a successful portfolio of pharmaceutical products and vaccines including: Mature brands Generics Over the counter (OTC) pharmaceuticals Difficult to develop medicines Value added presentations Biological products including vaccines: